Staley Tells Congress He Fed JPMorgan Secrets to Epstein

Former JPMorgan Chase executive Jes Staley told U.S. lawmakers he repeatedly shared confidential and market-sensitive bank information with Jeffrey Epstein and was at one point named as a trustee of Epstein's estate, according to a transcript released by the House Oversight Committee.

Jes Staley, once one of the most senior executives inside JPMorgan Chase and later chief executive of Barclays, has told U.S. lawmakers that he repeatedly shared confidential and market-sensitive information about the bank with Jeffrey Epstein. He also said he was at one point named as a trustee of Epstein's estate. The admissions appear in a transcript released by the U.S. House Oversight Committee and reported by BNN Bloomberg.

The two phrases doing the work here are "confidential" and "market-sensitive." The first describes a breach of an employer's internal rules. The second describes something that, depending on what was shared and what was done with it, sits closer to the territory regulators police: information that could move a security's price if it reached the wrong hands. Staley's own account, given to a congressional committee and now on the public record, is what makes this different from the years of allegation and inference that preceded it.

What the transcript actually establishes

Three things, and only three, are established by the material released. Staley said the sharing was repeated rather than a one-off. He said the information was both confidential and market-sensitive. And he confirmed that he was named at some stage as a trustee of Epstein's estate — a role that implies a degree of trust and proximity well beyond a banker-client relationship, and one that will interest anyone reconstructing who knew what about the disposition of Epstein's assets.

What the transcript does not do, on the facts released, is specify which information changed hands, when, whether anyone traded on it, or what JPMorgan knew at the time. Those gaps are the whole game for lawyers on every side. An admission of disclosure is not, by itself, an admission of a securities violation; the elements of insider trading require a tipper, a tippee, a breach of duty and, in most formulations, a personal benefit and a trade. Nothing in the released summary addresses trades.

Why the estate trusteeship is the sharper detail

Investigators tend to be drawn to fiduciary roles because they generate documents. A trusteeship implies drafting, signatures, dates and, often, correspondence about assets and beneficiaries. Being named a trustee does not mean a person accepted or served in the role, and the released material does not say he did. But the mere naming is a datable, documentary fact — the kind of thing a committee can subpoena around rather than argue about.

It also complicates the standard defense in cases like this, which is that the relationship was professional and the executive was managing a client. A client relationship does not ordinarily end with the client's estate planning documents naming his banker as trustee. That is the tension the Oversight Committee will press.

The exposure, for the man and for the bank

Staley's regulatory history in the United Kingdom already turns on the Epstein relationship: British authorities banned him from senior finance roles over how that relationship was characterized to regulators. An admission recorded in a U.S. congressional transcript does not automatically travel across the Atlantic, but it does hand any authority reviewing the matter a fresh primary source in Staley's own words — and it narrows the room to argue about the substance of the relationship rather than its description.

For JPMorgan Chase, the calculus is different. The bank has already settled Epstein-related litigation, and settlements typically buy finality with the plaintiffs who signed them, not with Congress, and not with regulators exercising supervisory powers. The risk to the bank from a transcript like this is less a new headline liability and more the reopening of a supervisory question: what controls governed the sharing of confidential and market-sensitive information by senior executives, and did they work? That question has an answer that costs money — compliance spending, remediation, occasionally a consent order — whether or not any new case is filed.

There is also the matter of who else is named as the committee works through its material. Congressional document releases arrive in tranches. Investors who assume this is a closed chapter should note that the release of one transcript usually signals the existence of others.

The market reaction: essentially none

There is also the matter of who else is named as the committee works through its material.

Shares in JPMorgan Chase (JPM) last changed hands at 356.50, down 0.05% from the prior close of 356.69, with the session ranging between 354.60 and 358.35, as of the close on Aug. 26, 2026. That is a flat tape by any definition, and it sits inside a broadly unmoved market: the S&P 500 tracker closed at $766.08, up 0.02%, the Nasdaq 100 tracker at $711.37, up 0.09%, and the Dow tracker at $534.23, down 0.19%.

The read-through is straightforward. Equity markets price cash flows and quantifiable liabilities. A former executive's testimony about conduct from a prior era, at a bank that has already settled the associated civil litigation, does not change next quarter's net interest income. Reputational stories move bank stocks when they carry a number attached — a fine, a capital add-on, a business restriction. None of those exist here yet.

What to watch from here

Whether the Oversight Committee releases further transcripts or documents naming other executives or institutions, and whether any of them concern trading.
Whether U.S. authorities with securities jurisdiction signal interest in the "market-sensitive" characterization, as opposed to treating it as an internal-policy matter.
Whether UK authorities revisit their existing findings against Staley in light of statements made under a different jurisdiction's process.
Whether JPMorgan makes any disclosure about internal review or controls, which would be the first sign the bank sees a supervisory rather than purely historical problem.
Whether the estate trusteeship draws parties from the Epstein estate litigation into the congressional record.

For now the story is documentary rather than financial. A senior banker has said, on the record, that he repeatedly gave a client confidential and market-sensitive information about the institution that employed him. Whatever follows will be built on that sentence.

Key facts

JPM last price: 356.50, -0.05%, at the close on Aug. 26, 2026
Admission: Staley says he repeatedly shared confidential, market-sensitive bank information with Epstein
Fiduciary role: Staley was at one point named a trustee of Epstein's estate
Source of statements: Transcript released by the U.S. House Oversight Committee

Frequently asked questions

What exactly did Jes Staley admit to?

According to a transcript released by the U.S. House Oversight Committee, the former JPMorgan Chase executive told lawmakers he repeatedly shared confidential and market-sensitive information about the bank with Jeffrey Epstein. He also confirmed that he was at one point named as a trustee of Epstein's estate. The released material does not specify which information was shared or when.

Does sharing market-sensitive information mean insider trading occurred?

Not automatically. Insider trading cases generally require a breach of duty, a recipient who knew or should have known of that breach, and trading on the information, often with a personal benefit to the tipper. Nothing in the released summary of Staley's testimony addresses whether any trades were made on what he described sharing.

How did JPMorgan Chase shares react?

They barely moved. JPM last changed hands at 356.50, down 0.05% from the prior close of 356.69, in a session ranging from 354.60 to 358.35 as of the Aug. 26, 2026 close. Broad benchmarks were similarly flat, with the S&P 500 tracker up 0.02% and the Nasdaq 100 tracker up 0.09%.

Why does the estate trusteeship matter?

A fiduciary role such as trustee implies dated documents, signatures and correspondence, which give investigators subpoena targets rather than contested recollections. It also cuts against the argument that the relationship was purely a professional banker-client arrangement, since estate planning documents naming a banker as trustee suggest considerably closer ties.

Hasn't JPMorgan already settled Epstein-related claims?

The bank has previously settled Epstein-related litigation. Settlements bind the parties who sign them, but they do not bar congressional inquiry or supervisory action by regulators. The practical risk to the bank from testimony like this is renewed scrutiny of the internal controls governing how senior executives handled confidential information.

What is Staley's existing regulatory status in the UK?

British authorities banned Staley from senior finance roles over how his relationship with Epstein was characterized to regulators. Statements he has now made to a U.S. congressional committee do not carry automatic effect in the UK, but they add a primary-source account in his own words that any reviewing authority could consider.

Sources

Former JPMorgan executive Staley says he shared confidential bank information with Epstein — BNN Bloomberg

Photo: khezez | خزاز · Pexels Licence — source